{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:02:34Z","timestamp":1769929354245,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00261-017-1316-z","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T14:49:45Z","timestamp":1505227785000},"page":"505-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Utility of (18) F-FDG PET\/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Sampanna","family":"Rayamajhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rohren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"1316_CR1","first-page":"277","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA 60:277\u2013300","journal-title":"CA"},{"key":"1316_CR2","first-page":"132","volume":"8","author":"G Barugola","year":"2007","unstructured":"Barugola G, Falconi M, Bettini R, et al. (2007) The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP 8:132\u2013140","journal-title":"JOP"},{"key":"1316_CR3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","volume":"21","author":"C Sperti","year":"1997","unstructured":"Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195\u2013200","journal-title":"World J Surg"},{"key":"1316_CR4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00261-002-0048-9","volume":"28","author":"JK Kim","year":"2003","unstructured":"Kim JK, Ha HK, Han DJ, Auh YH (2003) CT analysis of postoperative tumor recurrence patterns in periampullary cancer. Abdom Imaging 28:384\u2013391","journal-title":"Abdom Imaging"},{"key":"1316_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1245\/s10434-012-2762-z","volume":"20","author":"O Strobel","year":"2013","unstructured":"Strobel O, Hartwig W, Hackert T, et al. (2013) Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20:964\u2013972","journal-title":"Ann Surg Oncol"},{"key":"1316_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.surg.2013.06.050","volume":"155","author":"M Miyazaki","year":"2014","unstructured":"Miyazaki M, Yoshitomi H, Shimizu H, et al. (2014) Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile? Surgery 155:58\u201366","journal-title":"Surgery"},{"key":"1316_CR7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11605-012-1912-8","volume":"16","author":"RM Thomas","year":"2012","unstructured":"Thomas RM, Truty MJ, Nogueras-Gonzalez GM, et al. (2012) Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16:1696\u20131704","journal-title":"J Gastrointest Surg"},{"key":"1316_CR8","first-page":"34","volume":"7","author":"R Wilkowski","year":"2006","unstructured":"Wilkowski R, Thoma M, Bruns C, Duhmke E, Heinemann V (2006) Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 7:34\u201340","journal-title":"JOP"},{"key":"1316_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-8-27","volume":"8","author":"D Habermehl","year":"2013","unstructured":"Habermehl D, Brecht IC, Bergmann F, et al. (2013) Chemoradiation in patients with isolated recurrent pancreatic cancer\u2014therapeutical efficacy and probability of re-resection. Radiat Oncol 8:27","journal-title":"Radiat Oncol"},{"key":"1316_CR10","first-page":"1685","volume":"32","author":"H Horiuchi","year":"2005","unstructured":"Horiuchi H, Uchida S, Hisaka T, et al. (2005) A study of recurrent pancreatic cancer with metastatic liver tumors after pancreatectomy. Gan to kagaku ryoho. Cancer Chemother 32:1685\u20131687","journal-title":"Gan to kagaku ryoho. Cancer Chemother"},{"key":"1316_CR11","first-page":"419","volume":"36","author":"F Safi","year":"1989","unstructured":"Safi F, Roscher R, Beger HG (1989) Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9. Hepatogastroenterology 36:419\u2013423","journal-title":"Hepatogastroenterology"},{"key":"1316_CR12","doi-asserted-by":"crossref","first-page":"e78977","DOI":"10.1371\/journal.pone.0078977","volume":"8","author":"JK Park","year":"2013","unstructured":"Park JK, Paik WH, Ryu JK, et al. (2013) Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution. PLoS ONE 8:e78977","journal-title":"PLoS ONE"},{"key":"1316_CR13","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00259-010-1440-2","volume":"37","author":"K Kitajima","year":"2010","unstructured":"Kitajima K, Suzuki K, Nakamoto Y, et al. (2010) Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT studies for the diagnosis of uterine cancer recurrence. Eur J Nucl Med Mol Imaging 37:1490\u20131498","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1316_CR14","first-page":"250","volume":"40","author":"A Frohlich","year":"1999","unstructured":"Frohlich A, Diederichs CG, Staib L, et al. (1999) Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med 40:250\u2013255","journal-title":"J Nucl Med"},{"key":"1316_CR15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF02305535","volume":"4","author":"RC Montgomery","year":"1997","unstructured":"Montgomery RC, Hoffman JP, Riley LB, et al. (1997) Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 4:551\u2013556","journal-title":"Ann Surg Oncol"},{"key":"1316_CR16","doi-asserted-by":"crossref","first-page":"531640","DOI":"10.1155\/2013\/531640","volume":"2013","author":"G Bertino","year":"2013","unstructured":"Bertino G, Ardiri AM, Calvagno GS, et al. (2013) Carbohydrate 19.9 antigen serum levels in liver disease. BioMed Res Int 2013:531640","journal-title":"BioMed Res Int"},{"issue":"Pt 1","key":"1316_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/000456329803500113","volume":"35","author":"S Maestranzi","year":"1998","unstructured":"Maestranzi S, Przemioslo R, Mitchell H, Sherwood RA (1998) The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA. Ann Clin Biochem 35(Pt 1):99\u2013103","journal-title":"Ann Clin Biochem"},{"key":"1316_CR18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-005-2559-z","volume":"50","author":"JL Parra","year":"2005","unstructured":"Parra JL, Kaplan S, Barkin JS (2005) Elevated CA 19-9 caused by Hashimoto\u2019s thyroiditis: review of the benign causes of increased CA 19-9 level. Dig Dis Sci 50:694\u2013695","journal-title":"Dig Dis Sci"},{"key":"1316_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1155\/1993\/234238","volume":"11","author":"BR Osswald","year":"1993","unstructured":"Osswald BR, Klee FE, Wysocki S (1993) The reliability of highly elevated CA 19-9 levels. Dis Mark 11:275\u2013278","journal-title":"Dis Mark"},{"key":"1316_CR20","first-page":"189","volume":"30","author":"R Kannagi","year":"2007","unstructured":"Kannagi R (2007) Carbohydrate antigen sialyl Lewis a\u2014its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 30:189\u2013209","journal-title":"Chang Gung Med J"},{"issue":"Suppl 4","key":"1316_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/annonc\/10.suppl_4.S145","volume":"10","author":"R Lamerz","year":"1999","unstructured":"Lamerz R (1999) Role of tumour markers, cytogenetics. Ann Oncol 10(Suppl 4):145\u2013149","journal-title":"Ann Oncol"},{"key":"1316_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0016-5085(87)90840-7","volume":"92","author":"A Malesci","year":"1987","unstructured":"Malesci A, Tommasini MA, Bonato C, et al. (1987) Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis. Gastroenterology 92:60\u201367","journal-title":"Gastroenterology"},{"key":"1316_CR23","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","volume":"24","author":"GY Locker","year":"2006","unstructured":"Locker GY, Hamilton S, Harris J, et al. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313\u20135327","journal-title":"J Clin Oncol"},{"key":"1316_CR24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000658-199204000-00008","volume":"215","author":"F Tian","year":"1992","unstructured":"Tian F, Appert HE, Myles J, Howard JM (1992) Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma. Ann Surg 215:350\u2013355","journal-title":"Ann Surg"},{"key":"1316_CR25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1515\/cclm-2012-0458","volume":"51","author":"Y Tong","year":"2013","unstructured":"Tong Y, Song Z, Zhu W (2013) Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China. Clin Chem Lab Med 51:1459\u20131466","journal-title":"Clin Chem Lab Med"},{"key":"1316_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1478-3231.2009.02055.x","volume":"29","author":"E Waanders","year":"2009","unstructured":"Waanders E, van Keimpema L, Brouwer JT, et al. (2009) Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease. Liver Int 29:1389\u20131395","journal-title":"Liver Int"},{"key":"1316_CR27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MNM.0b013e32834f7dbe","volume":"33","author":"E Ozkan","year":"2012","unstructured":"Ozkan E, Soydal C, Araz M, Kir KM, Ibis E (2012) The role of 18F-FDG PET\/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Nucl Med Commun 33:395\u2013402","journal-title":"Nucl Med Commun"},{"key":"1316_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40644-015-0048-y","volume":"15","author":"M Gade","year":"2015","unstructured":"Gade M, Kubik M, Fisker RV, Thorlacius-Ussing O, Petersen LJ (2015) Diagnostic value of (18)F-FDG PET\/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA. Cancer Imaging 15:11","journal-title":"Cancer Imaging"},{"key":"1316_CR29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/IGC.0b013e3181e82a7f","volume":"20","author":"P Bhosale","year":"2010","unstructured":"Bhosale P, Peungjesada S, Wei W, et al. (2010) Clinical utility of positron emission tomography\/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer 20:936\u2013944","journal-title":"Int J Gynecol Cancer"},{"key":"1316_CR30","first-page":"331","volume":"70","author":"V Casneuf","year":"2007","unstructured":"Casneuf V, Delrue L, Kelles A, et al. (2007) Is combined 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Acta Gastroenterol Belg 70:331\u2013338","journal-title":"Acta Gastroenterol Belg"},{"key":"1316_CR31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11605-009-1010-8","volume":"14","author":"C Sperti","year":"2010","unstructured":"Sperti C, Pasquali C, Bissoli S, et al. (2010) Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastrointest Surg 14:131\u2013140","journal-title":"J Gastrointest Surg"},{"key":"1316_CR32","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3748\/wjg.v17.i9.1126","volume":"17","author":"T Heye","year":"2011","unstructured":"Heye T, Zausig N, Klauss M, et al. (2011) CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol 17:1126\u20131134","journal-title":"World J Gastroenterol"},{"key":"1316_CR33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M, et al. (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511\u2013518","journal-title":"J Gastrointest Surg"},{"key":"1316_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000085281","volume":"5","author":"J Ruf","year":"2005","unstructured":"Ruf J, Hanninen EL, Oettle H, et al. (2005) Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT\/MRI. Pancreatology 5:266\u2013272","journal-title":"Pancreatology"},{"key":"1316_CR35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11307-009-0271-7","volume":"12","author":"K Kitajima","year":"2010","unstructured":"Kitajima K, Murakami K, Yamasaki E, et al. (2010) Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET\/non-contrast-enhanced CT and enhanced CT. Mol Imaging Biol 12:452\u2013459","journal-title":"Mol Imaging Biol"},{"key":"1316_CR36","first-page":"429","volume":"39","author":"MB Menke-Pluymers","year":"1992","unstructured":"Menke-Pluymers MB, Klinkenbijl JH, Tjioe M, Jeekel J (1992) Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer. Hepato Gastroenterol 39:429\u2013432","journal-title":"Hepato Gastroenterol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-017-1316-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1316-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T15:26:10Z","timestamp":1519831570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-017-1316-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s00261-017-1316-z","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,12]]}}}